MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Biotechnology_Personalized, Precision, Preemptive Medicines
Nuclea Biotechnologies LLC
Parents
*Architects: Biotechnology_Personalized, Precision, Preemptive Medicines
*Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology
*Architects: Diagnostics_In Vitro Diagnostics (IVD)
Venture Capital: Series B
Children
Has developed its DecisionDX platform for diagnostic developments in cancer, including colon, stomach, leukemia, lung and prostate cancer, as well as cardiovascular, neurological, inflammation and metabolic disorders.
Nuclea Biotechnologies is a healthcare company dedicated to the development and commercialization of clinical diagnostic assays identifying gene and protein expression profiles characteristic of an individual's tumor or disease.
Nuclea Biotechnologies lands $3M funding (2011)
Pittsfield, Massachusetts